GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Transwarranty Finance Ltd

Transwarranty Finance Q1 FY27 Standalone Profit ₹5.19 Lakhs; Board Approves Fund Raising

RESULTS ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 31 Jul 2026, 06:33 PM IST  ·  BSE ID: 49fb69c7-e714-4c98-be9b-13143276267f
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported its first-quarter financial results, approved issuing private debt, and plans to raise more funds, pending shareholder approval.
🤖 AI Summary
  • Transwarranty Finance Board approved Unaudited Standalone Financial Results for Q1 FY27, reporting Profit for the Period of Rs. 5.19 Lakhs.
  • Board approved issuance of Unlisted Non-Convertible Debentures (NCDs) through private placement.
  • Approved raising funds via debt securities and External Commercial Borrowings, subject to shareholder approval at ensuing AGM.
  • Mr. Kumar Nair's re-appointment as MD & CEO for 3 years from September 1, 2026, approved, pending shareholder consent.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Standalone Profit/(Loss) For the Period (Q1 FY27)
Rs. 5.19 Lakhs
Standalone Profit/(Loss) For the Period (Q1 FY26)
Rs. -72.22 Lakhs
Consolidated Profit/(Loss) For the Period (Q1 FY27)
Rs. -12.10 Lakhs
Consolidated Profit/(Loss) For the Period (Q1 FY26)
Rs. -85.68 Lakhs
Not comparable — limited prior period data.
Standalone Total Revenue from Operations (Q1 FY27)
Rs. 255.09 Lakhs
Standalone Total Revenue from Operations (Q1 FY26)
Rs. 202.05 Lakhs
🏢 How This Affects the Company
📈
Business Impact
The approval for issuance of Unlisted Non-Convertible Debentures and plans for further debt securities and External Commercial Borrowings indicate an intent to bolster financial resources for business operations and growth. Re-appointment of the MD & CEO provides leadership continuity for strategic execution.
💰
Financial Impact
The approved NCDs and planned debt fund raising initiatives will increase the company's borrowing capacity, impacting its debt levels and potentially its finance costs. Standalone Profit for the Period stood at Rs. 5.19 Lakhs for Q1 FY27.
⚠️
Risk Impact
Increased debt through NCDs and planned borrowings will raise the company's financial leverage, potentially increasing interest expense burden. The change in accounting policy for investments in subsidiaries and associates impacts comparability of financial data with previous periods.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will need to vote on proposals for fund raising via debt securities and External Commercial Borrowings, and the re-appointment of Mr. Kumar Nair as MD & CEO at the ensuing Annual General Meeting.
👤
Who Is Affected
All shareholders are affected by the company's financial performance and future capital structure. Shareholders will determine the approval of management's fund-raising and re-appointment proposals.
🔍
Management Signal
Management intends to strengthen the company's financial position through debt capital and maintain leadership continuity by re-appointing the current MD & CEO.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Outcome of ensuing Annual General Meeting regarding fund raising proposals.
Board's decision on the specific terms and quantum of Unlisted NCDs.
Announcement of Q2 FY27 financial results for continued performance monitoring.
MEDIUM RISK Increased debt exposure from NCDs and planned borrowings, alongside non-comparable consolidated financial data, signals heightened financial risk.
💡 Investor Takeaway
Transwarranty Finance reported a Q1 FY27 Standalone Profit of Rs. 5.19 Lakhs, up from a Rs. 72.22 Lakhs loss YoY. The Board approved fund raising via Unlisted NCDs and plans for debt securities and External Commercial Borrowings are subject to shareholder approval.
⚖️ Strengths & Concerns

✅ Positives

  • Standalone Profit for the Period for Q1 FY27 was Rs. 5.19 Lakhs, a turnaround from a loss of Rs. 72.22 Lakhs in the prior comparable quarter.
  • Total Standalone Revenue from Operations for Q1 FY27 increased to Rs. 255.09 Lakhs from Rs. 202.05 Lakhs in the prior comparable quarter.

⚠️ Concerns

  • Consolidated Profit for the Period for Q1 FY27 was a loss of Rs. 12.10 Lakhs, following a loss of Rs. 85.68 Lakhs in the prior comparable quarter.
  • Consolidated figures for the quarter ended June 30, 2025, are not comparable due to a change in the status of investment in Vertex Securities Limited.
📅 Company Track Record
Transwarranty Finance Ltd reported Q4 FY26 PAT of ₹7.09 crore. This filing follows a previous announcement on July 28, 2026, regarding the Board meeting to consider Q1 FY27 results and fund raising. The company's digital AUM was reported up 61% YoY in a May 2026 press release.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Transwarranty Finance's Standalone Profit for Q1 FY27?
Transwarranty Finance reported a Standalone Profit For the Period of Rs. 5.19 Lakhs for the quarter ended June 30, 2026.
What fund raising initiatives did Transwarranty Finance's Board approve?
The Board approved the issuance of Unlisted Non-Convertible Debentures (NCDs) on a Private Placement basis, and raising funds via debt securities and External Commercial Borrowings, subject to shareholder approval.
Why are Transwarranty Finance's consolidated Q1 FY27 results not comparable to Q1 FY26?
The consolidated figures are not comparable because Vertex Securities Limited ceased to be a subsidiary and became an associate effective March 30, 2026, due to reduced shareholding.
Who was re-appointed as MD & CEO for Transwarranty Finance?
Mr. Kumar Nair (DIN: 00320541) was approved for re-appointment as the Managing Director and Chief Executive Officer for a term of 3 years, effective September 01, 2026, subject to shareholder approval.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.